SCHEMBL3240877

SCHEMBL3240877

CCCC(COC(=O)OC1CCCCC1)OC(=O)OC1CCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.41
EPHX1 P07099 2/20 0.41
HTT P42858 2/20 0.37
CHRM2 P08172 2/20 0.35
CHRM1 P11229 2/20 0.35
CHRM3 P20309 2/20 0.35
ADRA1A P35348 1/20 0.35
CHRNA4 P43681 1/20 0.35
HTR3A P46098 1/20 0.35
KCNH2 Q12809 1/20 0.35
AKT1 P31749 3/20 0.34
AKT2 P31751 3/20 0.34
AKT3 Q9Y243 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
CYP19A1 P11511 2/20 0.34
CYP2C19 P33261 1/20 0.33
ALDH1A1 P00352 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PIK3R1 P27986 1/20 0.32
PIK3CA P42336 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8200348 0.83 NAAA (0.40) NAAAEPHX1HTTCHRM2CHRM1
SCHEMBL18856334 0.80 NAAA (0.41) NAAAEPHX1HTTCHRM2CHRM1
SCHEMBL19669582 0.80 AKT1 (0.38) NAAAEPHX1HTTAKT1AKT2
SCHEMBL19669585 0.79 EPHX1 (0.42) NAAAEPHX1HTTAKT1AKT2
SCHEMBL6443081 0.78 PRKCA (0.40) NAAAEPHX1CHRM2CHRM1CHRM3
SCHEMBL15444724 0.78 EPHX1 (0.41) NAAAEPHX1HTTAKT1AKT2
SCHEMBL6272147 0.77 NAAA (0.39) NAAAEPHX1HTTSMN1; SMN2CYP19A1
SCHEMBL8220029 0.77 EPHX1 (0.44) NAAAEPHX1HTTSMN1; SMN2CYP19A1
SCHEMBL304317 0.76 EPHX1 (0.44) NAAAEPHX1HTTCYP19A1CYP2C19
SCHEMBL6448762 0.76 CHRM2 (0.36) NAAAEPHX1CHRM2CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010035032-A1 CALCIUM ION CHANNEL MODULATORS & USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2010-04-01 WO disclosed